Y-Intercept (HK)’s Olema Pharmaceuticals OLMA Stock Holding History

Y-Intercept (HK)’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,375	Closed	-$1.35M	–	2044
2026 Q1	$1.35M	Buy	90,375 +53,176	+143%	+$1.18M	0.03%	909
2025 Q4	$930K	Buy	+37,199	New	+$662K	0.02%	1002
2025 Q2	–	Sell	-10,882	Closed	-$40.9K	–	1910
2025 Q1	$40.9K	Sell	10,882 -8,119	-43%	-$40.8K	﹤0.01%	1134
2024 Q4	$111K	Buy	+19,001	New	+$190K	0.01%	1098
2024 Q1	–	Sell	-11,319	Closed	-$159K	–	1646
2023 Q4	$159K	Buy	+11,319	New	+$152K	0.01%	1039

Other funds holding OLMA

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

AFC

Ares Financial Consulting Calabasas, California $139M AUM

Y-Intercept (HK)'s OLMA Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 90,375 shares — an estimated $1.35M sold.

Y-Intercept (HK) first reported a position in OLMA in Q4 2023 and held it in 5 quarters. The position peaked at $1.35M in Q1 2026. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Y-Intercept (HK) reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 90,375 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.35M.
Y-Intercept (HK) first reported a position in Olema Pharmaceuticals in Q4 2023 and held it in 5 quarters.
Y-Intercept (HK)'s Olema Pharmaceuticals position peaked at $1.35M in Q1 2026.
10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.